GTC work was in collaboration with Dana-Faber cancer Institute/Harvard Medical School, Georgetown University, Brigham and Women’s Hospital and National Institute of Medicine.
The publication highlights the importance of the state-of-the-art comprehensive testing performed at GTC.
Read the paper: https://www.nejm.org/
GTC presented abstracts at ASCO 2025 GTC’s posters from the 2025 Convention of the American Society of Clinical Oncology are now available for download. Please reach out with any questions.
Bruce Hough, Maher Albitar Clinical Lymphoma, Myeloma and Leukemia, Vol. 000, No.xxx, 1–3 © 2025 Published by Elsevier Inc. Keywords: CD19 dim, Diffuse large b-cell lymphoma, Relapsed/Refractory, Bispecific T-cell engagers,
Aishwarya Sridhar1 · Dylon Patel1 · Alexandra Della Pia2 · Tatyana A. Feldman2,3 · Lori A. Leslie2,3 · Andre H. Goy1,2 · Maher Albitar4 · Andrew Ip2,3Received: 27 June 2024 / Accepted: 19 November 2024© The Author(s) 2024 OPEN AbstractBackground CD19-directed chimeric antigen receptor (CAR) T-cell therapy has revolutionized
Get all the critical news and events sent straight to your inbox
